 Joanna Poczobutt
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Microenvironment | 7 | 2020 | 454 | 1.270 |
Why?
| | Macrophages, Alveolar | 3 | 2021 | 359 | 1.220 |
Why?
| | Lung Neoplasms | 9 | 2020 | 2220 | 1.010 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 6 | 0.800 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 6 | 0.800 |
Why?
| | Lysophospholipase | 1 | 2021 | 13 | 0.800 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 26 | 0.790 |
Why?
| | Carcinoma, Lewis Lung | 2 | 2019 | 13 | 0.730 |
Why?
| | Glycoproteins | 1 | 2021 | 319 | 0.690 |
Why?
| | Macrophages | 3 | 2021 | 1324 | 0.610 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2015 | 45 | 0.550 |
Why?
| | Pneumonia | 1 | 2021 | 592 | 0.530 |
Why?
| | Adenocarcinoma | 3 | 2017 | 812 | 0.510 |
Why?
| | Leukotrienes | 1 | 2013 | 35 | 0.470 |
Why?
| | Eicosanoids | 1 | 2013 | 57 | 0.470 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2019 | 451 | 0.460 |
Why?
| | Monocytes | 1 | 2016 | 513 | 0.450 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2011 | 317 | 0.400 |
Why?
| | Disease Models, Animal | 8 | 2022 | 3730 | 0.380 |
Why?
| | Breast | 1 | 2010 | 140 | 0.360 |
Why?
| | Mice | 15 | 2022 | 15520 | 0.340 |
Why?
| | T-Lymphocytes | 2 | 2017 | 1774 | 0.340 |
Why?
| | Mice, Knockout | 5 | 2021 | 2680 | 0.330 |
Why?
| | Epithelial Cells | 2 | 2011 | 963 | 0.310 |
Why?
| | Macrophage Activation | 2 | 2021 | 168 | 0.290 |
Why?
| | Mice, Inbred C57BL | 9 | 2022 | 4908 | 0.280 |
Why?
| | Group IV Phospholipases A2 | 2 | 2017 | 46 | 0.270 |
Why?
| | Neoplasm Transplantation | 2 | 2016 | 245 | 0.260 |
Why?
| | Myeloid Cells | 2 | 2019 | 128 | 0.250 |
Why?
| | PPAR gamma | 2 | 2019 | 188 | 0.250 |
Why?
| | Animals | 16 | 2022 | 33381 | 0.250 |
Why?
| | Cell Line, Tumor | 6 | 2019 | 2851 | 0.240 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2016 | 454 | 0.210 |
Why?
| | Programmed Cell Death 1 Receptor | 3 | 2020 | 197 | 0.210 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.200 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 11 | 0.200 |
Why?
| | Chitinases | 1 | 2021 | 10 | 0.200 |
Why?
| | CD11 Antigens | 1 | 2021 | 32 | 0.200 |
Why?
| | CD11b Antigen | 1 | 2021 | 59 | 0.200 |
Why?
| | Cell Size | 1 | 2021 | 86 | 0.200 |
Why?
| | Lectins | 1 | 2021 | 50 | 0.200 |
Why?
| | Cigarette Smoking | 1 | 2022 | 85 | 0.200 |
Why?
| | Disease Progression | 4 | 2019 | 2490 | 0.190 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 79 | 0.190 |
Why?
| | Transforming Growth Factor beta1 | 2 | 2019 | 164 | 0.190 |
Why?
| | Lung | 3 | 2022 | 3664 | 0.170 |
Why?
| | Phagocytosis | 1 | 2021 | 364 | 0.170 |
Why?
| | Culture Media, Conditioned | 3 | 2021 | 112 | 0.170 |
Why?
| | Eosinophils | 1 | 2021 | 282 | 0.170 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 327 | 0.170 |
Why?
| | Bone Marrow | 2 | 2017 | 255 | 0.160 |
Why?
| | Breast Neoplasms | 1 | 2010 | 1965 | 0.160 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 355 | 0.160 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2019 | 176 | 0.150 |
Why?
| | Trans-Activators | 1 | 2020 | 373 | 0.150 |
Why?
| | Receptors, Complement | 1 | 2017 | 115 | 0.150 |
Why?
| | Transcriptome | 2 | 2021 | 756 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 156 | 0.150 |
Why?
| | Ureteral Obstruction | 1 | 2017 | 59 | 0.150 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 409 | 0.150 |
Why?
| | Adventitia | 1 | 2016 | 39 | 0.140 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2016 | 56 | 0.140 |
Why?
| | Immunocompetence | 1 | 2016 | 43 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2017 | 144 | 0.140 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2016 | 236 | 0.140 |
Why?
| | Gene Expression | 1 | 2021 | 1489 | 0.140 |
Why?
| | Interferon-gamma | 1 | 2019 | 736 | 0.130 |
Why?
| | Cell Proliferation | 5 | 2019 | 2275 | 0.130 |
Why?
| | Nuclear Proteins | 1 | 2020 | 597 | 0.130 |
Why?
| | Neutrophils | 1 | 2021 | 1233 | 0.130 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1691 | 0.130 |
Why?
| | Complement Activation | 1 | 2017 | 350 | 0.130 |
Why?
| | Chemokines | 1 | 2016 | 230 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2016 | 182 | 0.120 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 462 | 0.120 |
Why?
| | Neointima | 1 | 2014 | 12 | 0.120 |
Why?
| | Paracrine Communication | 1 | 2014 | 57 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1137 | 0.120 |
Why?
| | Immunotherapy | 1 | 2017 | 493 | 0.110 |
Why?
| | Kidney Diseases | 1 | 2017 | 439 | 0.110 |
Why?
| | Vascular System Injuries | 1 | 2014 | 70 | 0.110 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2017 | 740 | 0.110 |
Why?
| | Lipid Metabolism | 1 | 2016 | 477 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 176 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2022 | 2025 | 0.110 |
Why?
| | Extracellular Matrix | 1 | 2016 | 446 | 0.110 |
Why?
| | Flow Cytometry | 1 | 2015 | 1085 | 0.110 |
Why?
| | Stem Cells | 1 | 2016 | 559 | 0.100 |
Why?
| | Gene Deletion | 1 | 2013 | 361 | 0.100 |
Why?
| | Coculture Techniques | 3 | 2021 | 208 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 984 | 0.100 |
Why?
| | Mammary Glands, Human | 1 | 2011 | 61 | 0.100 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 462 | 0.100 |
Why?
| | Cells, Cultured | 3 | 2021 | 4077 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 968 | 0.100 |
Why?
| | Cytoplasm | 1 | 2011 | 269 | 0.100 |
Why?
| | Colony-Forming Units Assay | 1 | 2010 | 93 | 0.090 |
Why?
| | Humans | 12 | 2022 | 118974 | 0.090 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 395 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1794 | 0.090 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2009 | 27 | 0.090 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2009 | 67 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1597 | 0.080 |
Why?
| | Metabolomics | 1 | 2013 | 550 | 0.080 |
Why?
| | Cell Communication | 1 | 2010 | 281 | 0.080 |
Why?
| | Mice, Nude | 1 | 2010 | 663 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 653 | 0.080 |
Why?
| | Signal Transduction | 3 | 2019 | 4709 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 827 | 0.080 |
Why?
| | Prognosis | 1 | 2016 | 3443 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 618 | 0.080 |
Why?
| | Carcinoma | 1 | 2009 | 204 | 0.080 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 292 | 0.080 |
Why?
| | Blotting, Western | 1 | 2010 | 1194 | 0.080 |
Why?
| | Male | 6 | 2021 | 57801 | 0.080 |
Why?
| | Female | 5 | 2021 | 61565 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2011 | 702 | 0.070 |
Why?
| | Cytokines | 2 | 2014 | 1900 | 0.070 |
Why?
| | Phenotype | 2 | 2014 | 3003 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 278 | 0.070 |
Why?
| | Mutation | 2 | 2019 | 3457 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1346 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2009 | 1167 | 0.060 |
Why?
| | Transcription Factors | 1 | 2011 | 1570 | 0.060 |
Why?
| | Inflammation | 1 | 2013 | 2566 | 0.060 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 79 | 0.050 |
Why?
| | Leukocytes | 1 | 2022 | 290 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 246 | 0.050 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 85 | 0.050 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Chemokine CXCL9 | 1 | 2019 | 22 | 0.040 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2019 | 53 | 0.040 |
Why?
| | Gene Silencing | 1 | 2019 | 177 | 0.040 |
Why?
| | Cattle | 1 | 2021 | 978 | 0.040 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 237 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 296 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 2017 | 32 | 0.040 |
Why?
| | Complement C3d | 1 | 2017 | 60 | 0.040 |
Why?
| | Complement C3 | 1 | 2017 | 192 | 0.040 |
Why?
| | Fibroblasts | 1 | 2021 | 842 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 356 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2017 | 253 | 0.040 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 181 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 483 | 0.030 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2014 | 18 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 285 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1059 | 0.030 |
Why?
| | Femoral Artery | 1 | 2014 | 175 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 460 | 0.030 |
Why?
| | Nuclear Export Signals | 1 | 2011 | 4 | 0.030 |
Why?
| | Nuclear Localization Signals | 1 | 2011 | 14 | 0.030 |
Why?
| | Transfection | 1 | 2014 | 888 | 0.030 |
Why?
| | Peptide Mapping | 1 | 2011 | 63 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2011 | 51 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 200 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 410 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1284 | 0.020 |
Why?
| | Thiazolidinediones | 1 | 2011 | 146 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2011 | 276 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2011 | 363 | 0.020 |
Why?
| | Protein Transport | 1 | 2011 | 412 | 0.020 |
Why?
| | Butadienes | 1 | 2009 | 33 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1753 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2011 | 823 | 0.020 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2009 | 189 | 0.020 |
Why?
| | Nitriles | 1 | 2009 | 155 | 0.020 |
Why?
| | Benzamides | 1 | 2009 | 176 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2071 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2871 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2707 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 827 | 0.020 |
Why?
| | Rats | 1 | 2014 | 5392 | 0.020 |
Why?
| | Pregnancy | 1 | 2016 | 5691 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2011 | 1032 | 0.020 |
Why?
| | Biomarkers | 1 | 2014 | 3588 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6412 | 0.010 |
Why?
|
|
Poczobutt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|